News
-
-
-
-
REGULATED PRESS RELEASE
MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Lagardère SA reports monthly information on voting rights and shares for March 31, 2025, in accordance with French regulations. Details include total shares, exercisable voting rights, and theoretical voting rights -
PRESS RELEASE
Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation on Pharming Group NV (NL0010391025) to EUR 2.30 target price. Second phase II trial of leniolisib for PIDs announced, acquisition of Abliva completed. Revenue potential >USD1bn -
-
-
-
-